Open AccessJournal Article
[Visceral Leishmaniasis (Kala-Azar)].
About:
This article is published in Münchener medizinische Wochenschrift.The article was published on 1979-05-18 and is currently open access. It has received 14 citations till now. The article focuses on the topics: Visceral leishmaniasis.read more
Citations
More filters
Journal ArticleDOI
Pentamidine: A Review
TL;DR: Pentamidine, recently released for clinical use, is effective in therapy for the hemolymphatic stage of Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia, with no appreciable increase in drug levels on successive dosing and no correlation between levels and creatinine clearance or adverse reactions.
Journal ArticleDOI
Pancreatitis Induced by Pentavalent Antimonial Agents During Treatment of Leishmaniasis
Robert A. Gasser,Alan J. Magill,Charles N. Oster,Eileen D. Franke,Max Grogl,Jonathan D. Berman +5 more
TL;DR: Standard Sbv regimens induce pancreatitis in almost all patients, but continued therapy is often tolerated; pancreatitis subsides when therapy is stopped, and rechallenge may be tolerated after a brief halt in treatment.
Journal ArticleDOI
Bacterial sepsis in patients with visceral leishmaniasis in Northwest Ethiopia.
Mengistu Endris,Yegnasew Takele,Desalegn Woldeyohannes,Moges Tiruneh,Rezika Mohammed,Feleke Moges,Lutgarde Lynen,Jan Jacobs,Johan van Griensven,Ermias Diro +9 more
TL;DR: Careful clinical evaluation for focal infections and prompt initiation of empiric antibiotic treatment appears warranted in VL patients, suggesting that focal infections could serve as sources for bacterial sepsis among Vl patients.
Journal ArticleDOI
Treatment with liposomal amphotericin B of a child affected with drug-resistant visceral leishmaniasis
Raffaella Giacchino,G Giambartolomei,Loredana Tasso,Anna Timitilli,Elio Castagnola,M Brisigotti,Concetta Micalizzi +6 more
Journal ArticleDOI
Repurposing azole antifungals into antileishmanials: Novel 3-triazolylflavanones with promising in vitro antileishmanial activity against Leishmania major.
Masoud Keighobadi,Saeed Emami,Mahdi Fakhar,Azar Shokri,Hassan Mirzaei,Saeed Hosseini Teshnizi +5 more
TL;DR: Among the tested compounds, the 4-chloro derivative (TF-2) was found to be the most potent one, being about 13 times more potent than fluconazole against promastigotes and can be considered as promising candidate for development of new antileishmanial agents.